Numerous potential antimicrobial applications of lactoferrin and probiotics were identified, including reducing the risk of sepsis, improving the symptomatic burden of HIV, reducing HCV burden, and improving the course of H. pylori, although the evidence base was small and the relevance of this research to dairy products is unknown. The gene discussed is LTF; the disease is Sepsis.